Updates to the Australian Pharmaceutical Benefits Scheme
22 May 2023
Update
Services Australia has published a release detailing new and amended listings of medications on the Australian Pharmaceutical Benefits Scheme (PBS), effective from 1 May 2023.
Amendments have been made to a range of medications on the PBS, including the following medications:
- Methylphenidate (Ritalin® LA) being amended to allow access for adults with a retrospective diagnosis of ADHD. This includes access to capsules containing methylphenidate hydrochloride 10 mg, 20 mg, 30 mg, 40 mg, 60mg (modified release).
- Naltrexone (Naltrexone GH®) having a reduction in authority level for the treatment of alcohol dependence.
Enquiries regarding new and amended listings can be directed to the PBS at pbs@health.gov.au.
More news & views
24 April 2024
The reality of loving an adult child with severe mental illness
Written by a community member of the RANZCP Community Collaboration Committee.
23 April 2024
Changes to PBS Authorities from 1 April 2024
The Australian PBS has provided updates on legislative changes affecting PBS Authorities.
22 April 2024
Member profile: Dr Helena Niu
Meet Dr Helena Niu, Psychiatry Registrar at Cairns and Hinterland HHS, and member of the RANZCP Raci...